TSP - Spark Newswire

1 minute read

News

TuSimple Says As Of March 15, Had ~$1B Of Cash, Short-Term Investments As Of December 31, 2022; Says Expects That December 2022 Reduction In Workforce Would Drive Between $55M-$65M Of Cash Compensation Savings

By Michael Horton

Today, 3:22 AM

-SEC Filing

TSP

2 minute read

Stocks React To February Jobs Report: The Winners And Losers

By AJ Fabino

Today, 3:22 AM

The markets have offered investors a rollercoaster ride this week, with a flurry of activity and developments that have sent shockwaves through various sectors.

ARLO

4 minute read

Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 3:22 AM

Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

ADMP

2 minute read

Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday

By Lisa Levin

Today, 3:22 AM

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.

1 minute read

HSBC Downgrades TuSimple Hldgs to Hold, Lowers Price Target to $2.2

By Benzinga Newsdesk

Today, 3:22 AM

HSBC analyst Yuqian Ding downgrades TuSimple Hldgs (NASDAQ:TSP) from Buy to Hold and lowers the price target from $15.9 to $2.2.

TSP

4 minute read

Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 3:22 AM

Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal epithelial defect.

$APE